Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your appetite creeps back a day or two before your next injection, you're not imagining it. Many people notice that Mounjaro's effects feel slightly less strong towards the end of the weekly cycle. That experience is real, has a straightforward pharmacological explanation, and doesn't automatically mean anything is wrong. Tirzepatide has a half-life of roughly five days, so blood levels do fall in the days before your next dose — the NHS medicines page for tirzepatide explains how the medicine works and what to expect. Whether the dip feels significant enough to affect your week is a different question, and this page goes through both the biology and what to do if it bothers you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common worry behind this question is that tolerance is setting in, that Mounjaro is losing its grip and will soon do nothing at all. That framing is worth correcting early, because the mechanism here is much more ordinary than it sounds.
Tirzepatide is given once a week precisely because it has a long enough half-life to sustain meaningful blood levels across seven days. But 'long-acting' and 'perfectly flat' aren't the same thing. After each injection, levels peak within about 24 hours and then gradually fall over the rest of the week. By day six or seven, you're at the lowest point of the cycle (the trough) and that's when some people notice appetite returning, energy dropping slightly, or a general sense that the medicine feels less present. This is a normal pharmacokinetic pattern, not a sign that the drug has failed or that your body has adapted to it.
The distinction matters. Tolerance, in a clinical sense, would mean Mounjaro producing less effect at the same blood concentration over time. What most people experience at the end of the week is simply lower concentration, not diminished response to that concentration. The two feel similar from the inside but have different implications. You can read more about how tirzepatide's effect changes during the week for a fuller picture of the cycle.
Not everyone notices the end-of-week dip equally. At lower doses (particularly early in treatment) the absolute difference between peak and trough is smaller, and the appetite-suppressing effect may feel more consistent across all seven days. As the dose climbs, peak effects can be stronger, which sometimes makes the relative fall towards the end of the week feel more pronounced by contrast. Some people on higher doses describe a 'day six hunger' they didn't have at 5mg.
There's also the question of what else is going on. Mounjaro slows gastric emptying and suppresses appetite through its dual action on GIP and GLP-1 receptors, as described in NICE's appraisal of tirzepatide (TA1026). If you're eating more protein, staying well-hydrated and keeping to a routine, the trough tends to feel less disruptive. Busy weeks, less sleep, or an unusually active stretch can amplify how hungry you feel regardless of where you are in the cycle.
Injection timing plays a smaller role than people expect. Moving your injection day is occasionally discussed, but that's a conversation for your prescriber, not something to adjust independently. The Mounjaro treatment overview covers the basics of how the weekly schedule is managed.
A gentle dip in appetite suppression in the last day or two before each dose is a known, accepted part of the weekly cycle. What's worth flagging to your prescriber is something different: if the 'wearing off' feeling is dramatic, starts happening from day three or four, or if the medicine seems to have no effect at any point in the week, that's a separate clinical question.
There are a few practical things that can change how well the medicine works: injection technique, rotating sites properly, storage conditions (the pen must be kept refrigerated between 2–8°C, exact guidance is in your Patient Information Leaflet), and whether anything else you're taking affects absorption. If any of those have changed, that's worth mentioning. People who find the end-of-week dip genuinely disruptive (affecting sleep, mood or their ability to make good food choices) often find that discussing a dose review with their prescriber is more useful than trying to manage it themselves.
If you're losing weight more slowly than expected alongside a pronounced weekly dip, the guide to slower weight loss on Mounjaro covers the most common reasons and what to do about them. If you've been wondering whether Mounjaro wears off by the end of the week, that page looks specifically at what happens in those final days of the cycle and how to make sense of it. If you've been noticing that Mounjaro seems to wear off as the week goes on, that page looks at why this happens and what it tends to mean in practice. For a closer look at how Mounjaro's effect holds up at the end of each week, including what a typical trough looks and feels like, the detail there may help you track your own pattern more clearly.
The good news is that the weekly cycle is predictable, and predictable things are manageable. Prescribers have several routes. A dose increase to the next step in the titration schedule is the most common clinical response when someone has been stable on their current dose for at least four weeks, is tolerating it well, and is experiencing a meaningful drop in effect. Dose changes aren't made casually, there's a clinical review behind every increase, and the titration schedule exists partly to protect against GI side effects that can come with moving too fast.
If you've recently transferred to a new dose or provider, your prescriber may want to see evidence of a few steady weeks before drawing conclusions about the end-of-week pattern. Some people find that the trough smooths out once they've been at a given dose for six to eight weeks, as their body settles into the level.
The right route to this conversation is your clinical team, not a forum. If you're weighing up your options for private treatment and want to understand what oversight looks like in practice, the about us page explains how clinical review works at nume. For questions about starting or switching treatment, speaking to our prescribers is the sensible first step, they review every consultation personally, the same day it's submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.